Zalcitabine
- CAS No.7481-89-2
- GradeIndustrial / Pharmaceutical
- Availability● In Stock
Zalcitabine (CAS 7481-89-2) is a pyrimidine nucleoside analogue intermediate used in advanced antiviral research and pharmaceutical synthesis.
Request Bulk PricingProduct Technical Details
Product Overview
Zalcitabine, chemically designated as 2',3'-dideoxycytidine (ddC), is a synthetic pyrimidine nucleoside analogue historically investigated for its antiviral properties. With the CAS registry number 7481-89-2, it serves primarily as a specialized intermediate in the development of complex pharmaceutical APIs and advanced organic synthesis pathways. As a regulated research compound, it is strictly intended for laboratory and industrial R&D use under compliant regulatory frameworks.
Specifications
| Molecular Formula | C9H13N3O3 |
|---|---|
| Molecular Weight | 211.22 g/mol |
| Appearance | White to off-white crystalline powder |
| Assay (HPLC) | ≥98.0% |
| Moisture | ≤1.0% |
| Melting Point | 217–218°C |
| Density | 1.57 g/cm³ |
| Boiling Point | 415°C |
| Flash Point | 204°C |
Industrial Applications
In compliance with international chemical safety and regulatory standards, Zalcitabine is utilized exclusively as a high-purity building block in controlled pharmaceutical research environments. Its primary role lies in the exploration of nucleoside-based therapeutic scaffolds and mechanistic studies in virology. It is not intended for human or veterinary therapeutic use.
- Serves as a critical intermediate in nucleoside analogue synthesis
- Supports structure-activity relationship (SAR) studies in antiviral drug discovery
- Manufactured under stringent quality control protocols for research-grade consistency
Storage conditions require a cool, dry, and well-ventilated area, away from incompatible materials. Packaging is typically provided in 25 kg drums, with custom configurations available upon request to meet institutional safety and handling requirements.
